Jacqueline M Kirby

Senior Vice President at Command Holdings Group, Inc.
  • Claim this Profile
Contact Information
Location
Greater Philadelphia

Topline Score

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

You need to have a working account to view this content. Click here to join now
David Nicoli

Jacqui worked for me when I was VP for Corporate Affairs at AstraZeneca and she was my client throughout her tenure at Jazz Pharmaceuticals where she was VP of Corporate Affairs and Government Relations. In her various roles, she has always been a dynamic, strategic leader who has delivered results in the right ways. In other words, she is highly talented with both the What and the How. I have seen Jacqui build, lead and manage teams. She hires and develops great talent; she cares for her people; and she always brings out the best in them. She is a consummate corporate affairs professional with true experience and expertise in brand, corporate and internal communications; state and federal government relations; advocacy and alliance development; corporate philanthropy: and business strategy. She also motivates and inspires her teams, setting high expectations for them and is always available to coach and encourage them to grow and shine. Finally, Jacqui has successfully worked closely for and with CEO’s, other C-Suite executives, and company Boards to help them achieve critical company objectives. She is a consummate professional and a wonderful human being. She would be an excellent Board member, an excellent C-Suite executive and a great strategic advisor.

Kristin Bhavnani

I had the privilege to work with Jacqui at two different organizations seeing her lead a variety of functions. Jacqui is an enterprise leader committed to analyzing and shaping external marketplaces to further corporate objectives. As a Corporate Affairs/Public Affairs executive, she has deep experience and strength in navigating complex environments/challenges and influencing stakeholders internally and externally driving tangible results across Communications, Patient Advocacy, Government Affairs and Corporate Giving at the Global and Regional/Country level. Jacqui is expert at building functions/creating Corporate Affairs best-in-class capabilities and is deeply committed to creating high performing teams while supporting her people across work-life integration challenges.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

    • United States
    • Government Relations Services
    • 1 - 100 Employee
    • Senior Vice President
      • Jan 2023 - Present
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Vice President, Corporate Affairs
      • 2021 - 2022

      Established first corporate affairs function at Spero Therapeutics, overseeing corporate, brand, and employee communications; government affairs and policy; and stakeholder engagement. Served as company leader for corporate communications and critical stakeholder engagement efforts with patient and disease state organizations, industry trade associations, and policy coalitions. Served as chief strategist for federal/state government affairs and as senior advisor to global CEO in Biotechnology Innovation Organization (BIO) role. • Led development and execution of new corporate and employee branding campaign to enhance leadership role in developing and commercializing novel treatments for multi-drug resistance (MDR) bacterial infections and rare diseases. • Developed and led all corporate and brand communications and stakeholder engagement for Tebipenem HBr, first oral candidate for the treatment of MDR Gram-Negative infections, including the publication in The New England Journal of Medicine (NEJM) of the results from the Phase 3 ADAPT-PO clinical trial for its investigational oral carbapenem antibiotic, tebipenem pivoxil hydrobromide (tebipenem HBr). • Managed strategy/execution of government relations and legislative priorities/issues, including AMR legislation, PASTEUR, pandemic preparedness, Medicare, Medicaid, pricing/intellectual property, and BARDA/DOD antimicrobial resistance (AMR) policy issues. • Led and managed all corporate and investor communications, announcing the reduction in its workforce by approximately 75% and a restructure of its operations due to Federal Drug Administration (FDA) Complete Response Letter (CRL) for Tebipenem HBr. Show less

    • Ireland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Vice President, Global Corporate Affairs & Government Relations
      • 2017 - 2021

      Hired by CEO and general counsel to establish first corporate affairs function at company. Recruited and formed talented 15-person department to lead global corporate reputation through strategic corporate and brand communications, government relations and public policy, patient advocacy, corporate sustainability, and corporate giving. Managed $17M budget, agencies, and consultants. • Led communications for FDA approval and launch of four products in neuroscience, hematology, and oncology therapeutic areas. • Co-led 2025 vision with investor relations in completing comprehensive rebuild and reintroduction to investors of company’s corporate strategy and communication. • Developed (in collaboration with patient organizations) non-branded disease awareness campaigns and Jazz corporate partnership. • Launched comprehensive charitable giving program in compliance with corporate integrity agreement (CIA). • Served as chief strategist for federal/state government affairs and as senior advisor to global CEO for Biotechnology Innovation Organization (BIO) board of director role. • Led global communications for GW Pharmaceuticals/Greenwich Biosciences acquisition, resulting in 60 top-tier global media and television news coverages, currently leading post-acquisition corporate brand evolution and positioning. Show less

    • Vice President
      • 2016 - 2017

      Served as senior public affairs and legislative strategist for a full-service business development firm specializing in the government sector. Provided corporate affairs strategic planning for Aerospace & Defense clients working with government agencies, specifically the Department of Defense (DOD), Department of Homeland Security (DHS), and Veterans Affairs (VA). Developed and supported corporate communications and advocacy efforts to build and enhance client brands. • Provided strategic government relations and corporate communications guidance for the Capture and Bid & Proposal efforts supporting Mack Defense to bid and win the US Army’s M917A3 Heavy Dump Truck. • Provided marketing communications strategy and guidance to clients, including Media Relations, Direct Marketing, Social Media, and Online Media Services. Show less

    • United States
    • Medical Practices
    • 1 - 100 Employee
    • Vice President, U.S. Government Affairs
      • 2012 - 2015

      Served as chief strategist for government affairs and senior advisor to global CEO in his role as PhRMA BOD. Led federal and state government affairs teams of 21 lobbyists and 20 consulting firms dispersed across the US, avoiding significant “pay for” budget to business units and enhancing Medicaid market access and R&D innovation incentive to advance blockbuster brands such as Nexium, Toprol XL, Pulmicort Respules, and Arimidex, plus 20 other post-patent expiry products. Managed multimillion dollar department budget.• Developed and led strategy to educate congressional leadership, committees, and patient groups regarding changes to American Pediatric Association revised RSV guidelines, resulting in company cost savings due to delayed implementation.• Led company’s political action committee, managing strategic distribution of over $1 Million fund.• Developed communications, alliance, and advocacy strategies driving business performance for $1B mature brand portfolio. Show less

    • Senior Director, Business Planning & Execution, Growth Business Unit
      • 2009 - 2012

      Served as chief of staff to VP commercial business, responsible for executing against $5B portfolio including Crestor, Brilinta, Seroquel, Symbicort, and the diabetes and oncology franchises. Assisted with driving results and meeting US revenue targets. Managed two teams, developing and executing annual product marketing plans and exceeding quarterly sales goals. Collaborated with marketing/sales and business insight, leading commercial launch initiatives.

    • Senior Director, Corporate Affairs, Strategic Planning & External Relations
      • 2007 - 2009

      Led strategic planning across US corporate affairs. Developed and executed strategic plans aligned to US and global business priorities. Led development of health care reform strategy serving as PhRMA platform for the Affordable Care Act. Coordinated and managed company’s industry association engagement, overseeing $19M budget for US trade association participation and engagement, including PhRMA and BIO. Led and executed (with PhRMA/member companies) $78M advocacy campaign in support of the Affordable Care Act. Directed AZ’s $1.4M political action committee and employee grassroots program. Show less

    • Director, Federal Government Affairs
      • 2003 - 2007

      Served as senior lobbyist overseeing legislative strategies and implementation of company’s priorities, including Federal Food Drug and Cosmetic Act, PDUFA IV, drug safety reform, illegal pharmacy manufacturing, drug importation, and direct-to-consumer advertising. Ensured internal alignment with policy, alliance and advocacy, federal reimbursement, PAC/grassroots, and trade association efforts. Developed and implemented political outreach and crisis management of public affairs matters, including Department of Justice-rate Integrity Agreement and commercial impact on the brand. Developed and executed $2M political engagement plan, coordinating company activities during 2004 Republican and Democratic National Conventions. Show less

    • United States
    • Pharmaceutical Manufacturing
    • 200 - 300 Employee
    • Director, Federal Government Affairs
      • 2001 - 2003

      Served as federal lobbyist representing America’s leading pharmaceutical research and biotechnology companies. Oversaw lobbying efforts impacting pharmaceutical industry, including Federal Food Drug and Cosmetic Act, intellectual property, Medicare Part D, Hatch-Waxman Reform, PDUFA III, direct-to-consumer advertising, drug importation, and vaccines. Served as federal lobbyist representing America’s leading pharmaceutical research and biotechnology companies. Oversaw lobbying efforts impacting pharmaceutical industry, including Federal Food Drug and Cosmetic Act, intellectual property, Medicare Part D, Hatch-Waxman Reform, PDUFA III, direct-to-consumer advertising, drug importation, and vaccines.

    • Director, Federal Government Affairs
      • 1999 - 2001

      Served as federal lobbyist for lobbying activities and legislative strategies for health insurance industry priorities, including Patient Bill of Rights, Medicare Part D, Medicare Plus Choice/Advantage Program, and Physician Antitrust legislation. Served as federal lobbyist for lobbying activities and legislative strategies for health insurance industry priorities, including Patient Bill of Rights, Medicare Part D, Medicare Plus Choice/Advantage Program, and Physician Antitrust legislation.

    • United States
    • Non-profit Organizations
    • 500 - 600 Employee
    • Associate Director
      • 1997 - 1999

      Served as federal lobbyist representing lobbying activities/legislative strategies impacting America’s registered and advanced practice nurses. Served as federal lobbyist representing lobbying activities/legislative strategies impacting America’s registered and advanced practice nurses.

    • Policy Analyst
      • 1992 - 1995

      Served as Policy Analyst for Committee Chair Thomas C. Norton, specializing in health care and gaming issues. Served as Policy Analyst for Committee Chair Thomas C. Norton, specializing in health care and gaming issues.

Education

  • Boston University
    Bachelor of Arts - BA, Liberal Arts
  • Harvard University
    Master of Arts - MA, Political Science

Community

You need to have a working account to view this content. Click here to join now